Michelle Tighe Nestor

Publications by Year

Research Areas

Lymphoma Diagnosis and Treatment, Ubiquitin and proteasome pathways, Chronic Lymphocytic Leukemia Research, Cancer-related gene regulation, 14-3-3 protein interactions

Most-Cited Works

• → Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905)(2011)54 cited
• → MLN0905, a Small-Molecule PLK1 Inhibitor, Induces Antitumor Responses in Human Models of Diffuse Large B-cell Lymphoma(2012)21 cited
• → Supplementary Figure 3 from MLN0905, a Small-Molecule <i>PLK1</i> Inhibitor, Induces Antitumor Responses in Human Models of Diffuse Large B-cell Lymphoma(2023)
• → Supplementary Table 2 from MLN0905, a Small-Molecule <i>PLK1</i> Inhibitor, Induces Antitumor Responses in Human Models of Diffuse Large B-cell Lymphoma(2023)
• → Supplementary Figure 1 from MLN0905, a Small-Molecule <i>PLK1</i> Inhibitor, Induces Antitumor Responses in Human Models of Diffuse Large B-cell Lymphoma(2023)
• → Supplementary Figure 4 from MLN0905, a Small-Molecule <i>PLK1</i> Inhibitor, Induces Antitumor Responses in Human Models of Diffuse Large B-cell Lymphoma(2023)
• → Supplementary Figure Legend from MLN0905, a Small-Molecule <i>PLK1</i> Inhibitor, Induces Antitumor Responses in Human Models of Diffuse Large B-cell Lymphoma(2023)